FDA Investigator

Brittany M Kershaw

Latest inspection on record: Pittsburgh, United States, June 2026 · records back to 2015

Foods & CosmeticsHuman DrugsMedical Devices & Rad HealthBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 148 inspections across 143 sites are on record.
  • 176 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-04.

At a glance

Inspections

148

Sites

143

Observations

176

Career since

Nov 2015

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Anwaar M. Saeed, M.D.4 Jun 2026Human Drugs
Summa Health System IRB26 May 2026Medical Devices & Rad Health
Keith A. Friedenberg, M.D.11 May 2026Human Drugs
Kenneth L. Urish, M.D.28 Apr 2026Human Drugs
Nashat Y. Gabrail, M.D.15 Apr 2026Human Drugs

Sites inspected

Anwaar M. Saeed, M.D.Pittsburgh, United States1 insp.
Summa Health System IRBAkron, United States1 insp.
Keith A. Friedenberg, M.D.Mentor, United States1 insp.
Kenneth L. Urish, M.D.Pittsburgh, United States1 insp.
Nashat Y. Gabrail, M.D.Canton, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Amy L Mccarthy16 shared
Jennifer M Heitz8 shared
Benjamin P Stewart7 shared
Christopher D Snyder4 shared
Annemarie Kleiza3 shared
Jennifer A Pruden2 shared
Jazmine N Still2 shared
Darren S Morgan2 shared

Full investigator report

Get the verbatim findings behind Brittany M Kershaw's 176 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators